Frank Rimerman Advisors’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BCM
Frank Rimerman Advisors's RGEN Position: Q2 2022 in Review
Frank Rimerman Advisors sold out of Repligen (RGEN) in Q2 2022, closing a stake of 2,138 shares — an estimated $402K sold.
Frank Rimerman Advisors first reported a position in RGEN in Q3 2021 and held it in 3 quarters. The position peaked at $566K in Q4 2021. 404 funds tracked by Wall St. Rank hold RGEN as of Q2 2022.
- Frank Rimerman Advisors reported no remaining Repligen position as of Q2 2022 after selling out during the quarter.
- Frank Rimerman Advisors sold 2,138 Repligen shares in Q2 2022, an estimated $402K.
- Frank Rimerman Advisors first reported a position in Repligen in Q3 2021 and held it in 3 quarters.
- Frank Rimerman Advisors's Repligen position peaked at $566K in Q4 2021.
- 404 funds tracked by Wall St. Rank held Repligen as of Q2 2022.
Based on Frank Rimerman Advisors's 13F filing for Q2 2022, filed 7 Sep 2023.